Searched for
NEO PHARMACEUTICALS
Mangalam Drugs & Organics bulk deal: Vijay Kedia sells 1.38 lakh shares worth Rs 48 lakhMicrocap Mangalam Drugs saw multiple bulk deals as Vijay Kedia’s firm sold shares, yet the stock rose five percent. Despite a month-long ra...- Inox Neo Energies acquires 250 MWp solar projects of SunSource EnergyInox Neo Energies has acquired 250 MWp of solar projects from SunSource Energy. The company is also acquiring an additional 50 MWp, bringin...
- JSW Energy shares zoom nearly 8% on signing Rs 12,468 cr definitive agreement with O2 PowerJSW Energy Share Price: Shares of JSW Energy rose 7.7% as its subsidiary JSW Neo Energy signed a definitive agreement to acquire O2 Power's...
- Stocks in news: IOL Chemicals, Alkyl Amines, Ola Electric, JSW Energy, Hero MotoCorpThe Indian arm of UK-headquartered pharmaceutical giant AstraZeneca has laid off more than 125 employees from its biopharmaceutical busines...
- For risk takers: 4 smallcaps with right mix of ROE and ROCE have upside scope of up to 27%As nifty touches all time high, more small caps stocks are likely to join the party. Infact for last many weeks, even on days when select s...
- Five firms together log Rs 12K cr in Q4 losses. Analysts positive on three of themNet-net analysts have positive views on Sun Pharma, Tata Motors and InterGlobe Aviation, neutral to negative views on Vodafone Idea and no ...
- Stocks in the news: JSW Steel, NMDC, Hindalco, ONGC, Tata Power and Paradeep PhosphatesJSW Steel, GAIL, Nykaa, United Spirits, Info Edge, Jindal Steel, Ruchi Soya, Astral, PB Fintech, Aarti Industries, Oil India, Sumitomo Chem...
- View: Cancel culture swoops down on vaccinatorsCancel culture being purely political - 'I reject vegetarianism because Hitler embraced vegetarianism' - vaccines are in a haraam list. The...
- VC fund 9Unicorns invests in NeoDocs along with two angel investorsNeoDocs interprets and simplifies medical reports to provide personalised health recommendations.
- Lupin looks to sell Japanese arm Kyowa for $600 millionKyowa grew a modest 5% over the year-ago level. Its net profit halved to Rs 68.6 crore constituting 11.3% of Lupin’s consolidated profit. "...
- Bullish on these 2 stocks in auto sector: Yogesh Mehta, Motilal Oswal SecuritiesAurobindo Pharma and Granules india are the two pharma stocks worth betting on
- Good demand from business travellers of tier-II, III, says GoAir chief“Businessmen specially from tier-II and III cities is going throughout the country and is not just focussed on the big cities but goes more...
- 25 years of reforms: Nehru built many strong institutions, almost all have eroded, says Swaminathan Aiyar"India used to be a leader of the G77 group of developing countries. But is now a member of G20, the biggest global powers."
- Twelve stocks in focus in Friday morning tradeThe Indian market is expected to open flat. Here is a list of top twelve stocks that are likely to be in focus today.
- NeoBiocon partners Novartis to launch diabetes drugs in UAENeoBiocon has received approvals from the Ministry of Health-UAE for marketing Jalra and Jalra-M in the country and the launch is scheduled...
- Indian businessman to set up pharma plant in Saudi ArabiaPraising Indian expatriates' sincerity to work and honesty in dealings, he underscored the need to further boost the excellent relations wi...
- Hyderabad's Hetero Group enters UAE with new ventureThe first phase of the collaboration will be distribution of Hetero's medicines in the UAE, Chairman of Hetero Group B P S Reddy said.
- 14 FDI proposals worth Rs 113.35 crore cleared: GovernmentThe government today said it has cleared 14 FDI proposals worth Rs 113.35 crore including three from the pharmaceutical sector.
- 'Only area where Indo-China ties doing well is commerce'The first visit of a major Chinese leader in more than four years has yielded a bland joint communiqué skirting core Indian concerns but in...
- Venus files patent application for anti-bacterial drugPharmaceutical firm Venus Remedies on Monday said it has filed a patent application for its combination drug for the treatment of multi-bac...
Load More
